Comparison of single dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache
- 1 April 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 39 (4) , 590
- https://doi.org/10.1212/wnl.39.4.590
Abstract
We treated 64 emergency room patients with a primary vascular headache with dihydroergotamine (DHE), meperidine, or butorphanol. Post-treatment pain scores were lowest in the DHE group (p <0.01). Eight of 21 patients receiving DHE had greater than 90% reduction in pain compared with three of 19 patients receiving butorphanol and none of 22 receiving meperidine.This publication has 2 references indexed in Scilit:
- Repetitive intravenous dihydroergotamine as therapy for intractable migraineNeurology, 1986
- A Controlled Study of Dihydroergotamine in the Treatment of Acute Migraine HeadacheHeadache: The Journal of Head and Face Pain, 1986